PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients (pts) with advanced solid tumors: Results of a phase I dose escalation and expansion study.
暂无分享,去创建一个
D. Xuan | M. Maitland | A. Tolcher | S. Kummar | E. Stringer-Reasor | V. Moreno | J. Sachdev | V. Boni | E. Calvo | T. Joh | A. Forero-Torres | Xiaohua Xin | N. Lakhani | E. Powell | A. Jackson-Fisher | B. Gibson | M. Sharma